Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $660.15 million. The enterprise value is $519.81 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 56.14 million shares outstanding. The number of shares has increased by 33.78% in one year.
Current Share Class | 54.68M |
Shares Outstanding | 56.14M |
Shares Change (YoY) | +33.78% |
Shares Change (QoQ) | +4.12% |
Owned by Insiders (%) | 0.76% |
Owned by Institutions (%) | 45.95% |
Float | 46.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 89.81 |
PS Ratio | 9.96 |
Forward PS | 4.95 |
PB Ratio | 5.53 |
P/TBV Ratio | 6.26 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 8.38 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.53.
Current Ratio | 7.85 |
Quick Ratio | 7.66 |
Debt / Equity | 0.53 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.12 |
Financial Efficiency
Return on equity (ROE) is 3.53% and return on invested capital (ROIC) is -27.82%.
Return on Equity (ROE) | 3.53% |
Return on Assets (ROA) | -18.85% |
Return on Invested Capital (ROIC) | -27.82% |
Return on Capital Employed (ROCE) | -26.56% |
Revenue Per Employee | $1.05M |
Profits Per Employee | -$66,237 |
Employee Count | 59 |
Asset Turnover | 0.31 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVRA has paid $18.75 million in taxes.
Income Tax | 18.75M |
Effective Tax Rate | 87.64% |
Stock Price Statistics
The stock price has increased by +38.47% in the last 52 weeks. The beta is 1.87, so ZVRA's price volatility has been higher than the market average.
Beta (5Y) | 1.87 |
52-Week Price Change | +38.47% |
50-Day Moving Average | 10.53 |
200-Day Moving Average | 8.72 |
Relative Strength Index (RSI) | 32.82 |
Average Volume (20 Days) | 1,303,133 |
Short Selling Information
The latest short interest is 4.64 million, so 8.27% of the outstanding shares have been sold short.
Short Interest | 4.64M |
Short Previous Month | 4.90M |
Short % of Shares Out | 8.27% |
Short % of Float | 10.09% |
Short Ratio (days to cover) | 3.44 |
Income Statement
In the last 12 months, ZVRA had revenue of $62.02 million and -$3.91 million in losses. Loss per share was -$0.08.
Revenue | 62.02M |
Gross Profit | 44.63M |
Operating Income | -60.41M |
Pretax Income | -50.87M |
Net Income | -3.91M |
EBITDA | -53.85M |
EBIT | -60.41M |
Loss Per Share | -$0.08 |
Full Income Statement Balance Sheet
The company has $202.61 million in cash and $62.28 million in debt, giving a net cash position of $140.34 million or $2.50 per share.
Cash & Cash Equivalents | 202.61M |
Total Debt | 62.28M |
Net Cash | 140.34M |
Net Cash Per Share | $2.50 |
Equity (Book Value) | 117.23M |
Book Value Per Share | 2.13 |
Working Capital | 197.51M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$46.21 million and capital expenditures -$312,000, giving a free cash flow of -$46.53 million.
Operating Cash Flow | -46.21M |
Capital Expenditures | -312,000 |
Free Cash Flow | -46.53M |
FCF Per Share | -$0.83 |
Full Cash Flow Statement Margins
Gross margin is 71.96%, with operating and profit margins of -97.41% and 4.26%.
Gross Margin | 71.96% |
Operating Margin | -97.41% |
Pretax Margin | 34.50% |
Profit Margin | 4.26% |
EBITDA Margin | -86.82% |
EBIT Margin | -97.41% |
FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.78% |
Shareholder Yield | -33.78% |
Earnings Yield | -0.59% |
FCF Yield | -7.05% |
Analyst Forecast
The average price target for ZVRA is $22.67, which is 140.40% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $22.67 |
Price Target Difference | 140.40% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 74.16% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
Last Split Date | Dec 28, 2020 |
Split Type | Reverse |
Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of -0.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.2 |
Piotroski F-Score | 2 |